BRIEF published on 05/07/2024 at 19:34, 1 year 10 months ago GenSight Biologics Announces Availability of Prospectus for New Shares Listing on Euronext Paris Euronext Paris Capital Increase Gene Therapy Prospectus GenSight Biologics
PRESS RELEASE published on 05/07/2024 at 19:29, 1 year 10 months ago Terms of availability of prospectuses GenSight Biologics announces availability of listing prospectus for new shares on Euronext Paris. The prospectus approved by AMF includes universal registration document, securities note, and summary Euronext Paris New Shares AMF Approval GenSight Biologics Listing Prospectus
Published on 03/15/2026 at 23:25, 11 hours 7 minutes ago Tunkillia 'Phase 2' Resource Upgrade Drilling Begins
Published on 03/15/2026 at 18:00, 16 hours 32 minutes ago SEG Announced 2025 Annual Results Initiating First Special Dividend Distribution Payout Ratio Reached 88% Newly Signed Orders Exceeded RMB100-Billion Mark for the Second Consecutive Year
Published on 03/13/2026 at 23:00, 2 days 11 hours ago CORRECTION FROM SOURCE: EV Nickel Announces Maiden Mineral Resource Estimate for Gemini North Nickel Zone
Published on 03/13/2026 at 23:00, 2 days 11 hours ago Redwood AI Announces Platform Name Change and Appointment of Dr. Mark Dybul as Public Safety & Defense Advisor
Published on 03/13/2026 at 21:30, 2 days 13 hours ago Alset AI Announces Closing of Shares for Debt Transaction
Published on 03/16/2026 at 10:20, 12 minutes ago EightSix Launches Brand Studio: The World's First Brand Music Intelligence System
Published on 03/16/2026 at 10:15, 17 minutes ago NVision and Aarhus University Awarded Innovation Fund Denmark Grant to Advance Clinical Translation of Quantum-Enhanced MRI
Published on 03/16/2026 at 10:05, 27 minutes ago AliExpress Anniversary Sale Hits up to 90% Off as Brand+ Channel Surges with Exclusive Tech Debuts and Price Guarantee
Published on 03/16/2026 at 10:00, 32 minutes ago REPLOID launches crowdfinancing campaign on Invesdor
Published on 03/16/2026 at 09:59, 33 minutes ago EQS-Adhoc: IBU-tec advanced materials AG publishes planning: Revenue expectation of at least EUR 120-140 million in 2030 and EUR 37- 39 million for 2026
Published on 03/16/2026 at 08:30, 2 hours 2 minutes ago CDA - Update on CDA' parks solarization program
Published on 03/13/2026 at 19:50, 2 days 14 hours ago Availability of ENGIE’S 2025 Universal Registration Document
Published on 03/13/2026 at 18:05, 2 days 16 hours ago Availability of the 2025 Universal Registration Document of OPmobility SE
Published on 03/13/2026 at 07:30, 3 days 3 hours ago BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Published on 03/12/2026 at 18:00, 3 days 16 hours ago NEW OR RENEWED AGREEMENTS BETWEEN EURAZEO AND CERTAIN FAMILY SHAREHOLDERS
